The forecast for stomach malignant neoplasms mortality in the US from 2024 to 2028 shows a stable trend, with mortality values consistently around 11.18 to 11.19 thousand deaths annually. In 2023, the number stood at approximately 11.18 thousand deaths. Over this period, the year-on-year change is negligible, hovering close to zero, indicating stability in the mortality rate.
Future trends to watch for include potential advancements in medical treatments and early detection technologies that could impact mortality rates. Additionally, lifestyle and dietary changes, along with public health initiatives, could play a role in altering future trends in stomach cancer mortality. Monitoring these factors will be crucial in understanding long-term implications.
